Join us at JPM26 in SF on Jan 12-13
No images? Click here
From oncology shifts to manufacturing scrambles: The discussions that count
JANUARY 12 - 13, 2026 | 7:00 AM - 5:00 PM PT
MARRIOTT MARQUIS, SAN FRANCISCO
The disconnect between biotech valuations and big pharma dealmaking has become one of the industry's defining features — small companies struggle for funding while acquirers pay premiums for the right assets. At Endpoints at JPM, we're exploring how companies are navigating this environment.
Starting with the deal landscape itself, John Carroll sits down with dealmakers from Amgen, PwC, and AbbVie to discuss the M&A surge that delivered multiple $10 billion acquisitions despite the broader downturn. They'll examine whether this momentum continues into 2026 or if buyers pull back. Which biotechs will survive, and which will become the next targets?
Save 15% when you buy a group pass — you can choose your attendees later
- Virtual passes are available at no charge
AGENDA HIGHLIGHTS
The oncology discussion features Foundation Medicine's Dan Malarek and the Parker Institute's John Connolly on the strategic shifts happening across R&D organizations: What's driving these changes and what do they mean for cancer drug development? Plus, companies working through the FDA's rare disease pathway share their experiences with the evolving regulatory landscape.
View the full agenda here.
Dan Malarek
CEO
Foundation Medicine
NEW: In-person passes include access to our invite-only networking reception, featuring a live taping of Post-Hoc Live and special guest Noubar Afeyan, Founder and CEO of Flagship Pioneering.
Manufacturing leaders from Novartis and Fujifilm discuss supply chain adjustments as trade policies shift. Brent Saunders and Vijay Pande explore how biopharma competes for AI talent against tech companies. We'll also reveal findings from our new Biopharma Sentiment Index, capturing where industry leaders think we're headed.
These conversations will help shape your agenda for navigating what's ahead. Join us.
Save 15% when you buy a group pass — you can choose your attendees later
- Virtual passes are available at no charge
Can't make it to SF?
Choose a virtual pass.
WHY ATTEND ENDPOINTS AT JPM26?
Real people, real conversations, real answers — get the full story from leaders on where we go from here.
Candid discussions about what actually works when funding plateaus and barriers keep rising.
The Endpoints Hub, a coworking space that offers sanctuary to meet, focus, and connect in the midst of the JPM frenzy.
EVENT SPONSORS
